120 related articles for article (PubMed ID: 26998131)
1. Genetic alterations of HER genes in chromophobe renal cell carcinoma.
Weng WH; Chen YT; Yu KJ; Chang YH; Chuang CK; Pang ST
Oncol Lett; 2016 Mar; 11(3):2111-2116. PubMed ID: 26998131
[TBL] [Abstract][Full Text] [Related]
2. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
3. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
[TBL] [Abstract][Full Text] [Related]
4. Smoking enhanced the expression of c-kit in chromophobe renal cell carcinoma.
Jiang J; Yang L; Chen M; Xiao F; Zeng Y; Zhu H; Li Y; Liu L
Tob Induc Dis; 2023; 21():126. PubMed ID: 37808589
[TBL] [Abstract][Full Text] [Related]
5. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
6. Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma.
Ohashi R; Schraml P; Batavia A; Angori S; Simmler P; Rupp N; Ajioka Y; Oliva E; Moch H
Transl Oncol; 2019 Sep; 12(9):1131-1137. PubMed ID: 31200327
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
Ahmed EA; Youssif ME
J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
[TBL] [Abstract][Full Text] [Related]
9. Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype.
Ohashi R; Schraml P; Angori S; Batavia AA; Rupp NJ; Ohe C; Otsuki Y; Kawasaki T; Kobayashi H; Kobayashi K; Miyazaki T; Shibuya H; Usuda H; Umezu H; Fujishima F; Furusato B; Osakabe M; Sugai T; Kuroda N; Tsuzuki T; Nagashima Y; Ajioka Y; Moch H
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623347
[TBL] [Abstract][Full Text] [Related]
10. c-Met in chromophobe renal cell carcinoma.
Erlmeier F; Ivanyi P; Hartmann A; Autenrieth M; Wiedemann M; Weichert W; Steffens S
Med Oncol; 2017 Feb; 34(2):15. PubMed ID: 28035577
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
12. Identification of
Wang S; Yu ZH; Chai KQ
Oncol Lett; 2019 Aug; 18(2):1767-1774. PubMed ID: 31423244
[TBL] [Abstract][Full Text] [Related]
13. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Linehan WM; Ricketts CJ
Nat Rev Urol; 2019 Sep; 16(9):539-552. PubMed ID: 31278395
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma.
Kojima F; Matsuzaki I; Kuroda N; Mikasa Y; Musangile FY; Iwamoto R; Takahashi Y; Matsubara A; Kohjimoto Y; Hara I; Murata SI
Clin Pathol; 2021; 14():2632010X211064821. PubMed ID: 34927071
[TBL] [Abstract][Full Text] [Related]
15. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
[TBL] [Abstract][Full Text] [Related]
16. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
[TBL] [Abstract][Full Text] [Related]
17. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
18. Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.
Ohashi R; Angori S; Batavia AA; Rupp NJ; Ajioka Y; Schraml P; Moch H
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32079343
[TBL] [Abstract][Full Text] [Related]
19. Use of FISH analysis for diagnosis of renal cell carcinoma subtypes.
Iqbal MA; Akhtar M; Al Dayel F; Ulmer C; Paterson MC
Ann Saudi Med; 1999; 19(6):495-500. PubMed ID: 17277466
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients.
Sassen A; Rochon J; Wild P; Hartmann A; Hofstaedter F; Schwarz S; Brockhoff G
Breast Cancer Res; 2008; 10(1):R2. PubMed ID: 18182100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
